STXB1 gene therapy (Biogen)

N/A

Report date: 2025/06/11 10:53:37

Base Information

Drug NameSTXB1 gene therapy (Biogen)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionSyntaxin-binding protein 1 gene transference
TargetsSyntaxin-binding protein 1
Therapy Area/IndicationsDevelopmental and epileptic encephalopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiogen Inc
Inactive CompaniesN/A
Active IndicationsDevelopmental and epileptic encephalopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A